Completed PHASE1 INTERVENTIONAL 2-arm NCT01916408

The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon (Enzy-MagIC)

The Effects of Oral Proteolytic and Hydrolytic Enzymes and Flavonoids on Inflammatory Markers and Coagulation After Marathon Running

Sponsor: Technical University of Munich

Conditions Blood Coagulation Disorders Cardiovascular Diseases Death Death, Sudden Death, Sudden, Cardiac Heart Diseases Inflammation Pathologic Processes Respiratory Tract Infections

Interventions PL 1 Wobenzym plus

Updated 6 times since 2017 Last updated: Jun 29, 2015 Started: Aug 31, 2013 Primary completion: Jan 31, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01916408, this PHASE1 trial focuses on Blood Coagulation Disorders and Cardiovascular Diseases and remains completed. Sponsored by Technical University of Munich, it has been updated 6 times since 2013, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Nov 2022 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Nov 2022 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Technical University of Munich

Data source: Technical University of Munich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Munich, Germany